|
DPM3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.479700E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.438300E-02 |
| Normal-vs-Stage2 |
1.592170E-01 |
| Normal-vs-Stage3 |
7.786400E-02 |
| Normal-vs-Stage4 |
2.776200E-01 |
| Stage1-vs-Stage2 |
7.764000E-01 |
| Stage1-vs-Stage3 |
7.055800E-01 |
| Stage1-vs-Stage4 |
6.922000E-01 |
| Stage2-vs-Stage3 |
9.937800E-01 |
| Stage2-vs-Stage4 |
6.271800E-01 |
| Stage3-vs-Stage4 |
5.515200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.718000E-02 |
| Normal-vs-AfricanAmerican |
7.914600E-01 |
| Normal-vs-Asian |
1.471620E-01 |
| Caucasian-vs-AfricanAmerican |
4.483700E-02 |
| Caucasian-vs-Asian |
9.223600E-01 |
| AfricanAmerican-vs-Asian |
1.222020E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.782300E-02 |
| Normal-vs-Female |
1.005760E-01 |
| Male-vs-Female |
4.623400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.852300E-02 |
| Normal-vs-Age(41-60Yrs) |
5.063900E-02 |
| Normal-vs-Age(61-80Yrs) |
1.947970E-01 |
| Normal-vs-Age(81-100Yrs) |
2.081400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.833800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.783600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.922000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.609800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.947200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.016800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.851620E-01 |
| Classical-VS-Follicular |
6.199200E-03 |
| Classical-VS-Other |
2.338600E-01 |
| Classical-VS-Normal |
1.877650E-01 |
| Tall-VS-Follicular |
8.815500E-03 |
| Tall-VS-Other |
9.322300E-02 |
| Tall-VS-Normal |
7.976600E-01 |
| Follicular-VS-Other |
8.208200E-01 |
| Follicular-VS-Normal |
1.939220E-03 |
| Other-VS-Normal |
8.523700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.810100E-02 |
| Normal-vs-N1 |
1.300400E-02 |
| N0-vs-N1 |
2.531800E-01 |
|
|
